Literature DB >> 976132

Aminoglycosides: do we need new agents?

H C Neu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976132     DOI: 10.2165/00003495-197612030-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  13 in total

1.  Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups.

Authors:  R Benveniste; J Davies
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

2.  A virulent nosocomial Klebsiella with a transferable R factor for gentamicin: emergence and suppression.

Authors:  C M Martin; N S Ikari; J Zimmerman; J A Waitz
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

3.  Resistance of Pseudomonas aeruginosa to gentamicin and related aminoglycoside antibiotics.

Authors:  R K Holmes; B H Minshew; I K Gould; J P Sanford
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

4.  Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

Authors:  W H Greene; M Moody; S Schimpff; V M Young; P H Wiernik
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

5.  R factor-mediated resistance to gentamicin in a clinical isolate of Escherichia coli.

Authors:  S A Kabins; C R Nathan; S Cohen
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  In vitro study of netilmicin compared with other aminoglycosides.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

7.  Amikacin therapy for serious gram-negative bacillary infections.

Authors:  R D Meyer; R P Lewis; E D Carmalt; S M Finegold
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

8.  Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.

Authors:  M F Parry; H C Neu
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

9.  R factors in gentamicin-resistant organisms causing hospital infection.

Authors:  A S Richmond; M S Simberkoff; J J Rahal; S Schaefler
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

10.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

View more
  1 in total

Review 1.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.